The vitamin B 12 family of cofactors known as cobamides are essential for a variety of microbial 22 metabolisms. We used comparative genomics of 11,000 bacterial species to analyze the extent 23 36 37 --38 39 40
and distribution of cobamide production and use across bacteria. We find that 86% of bacteria in 24 this data set have at least one of 15 cobamide-dependent enzyme families, yet only 37% are 25 predicted to synthesize cobamides de novo. The distribution of cobamide biosynthesis varies at 26 the phylum level, with 57% of Actinobacteria, 45% of Proteobacteria, and 30% of Firmicutes, 27 and less than 1% of Bacteroidetes containing the complete biosynthetic pathway. Cobamide 28 structure could be predicted for 58% of cobamide-producing species, based on the presence of 29 signature lower ligand biosynthesis and attachment genes. Our predictions also revealed that 30 17% of bacteria that have partial biosynthetic pathways, yet have the potential to salvage 31 cobamide precursors. These include a newly defined, experimentally verified category of 32 bacteria lacking the first step in the biosynthesis pathway. These predictions highlight the 33 importance of cobamide and cobamide precursor crossfeeding as examples of nutritional 34 dependencies in bacteria. 35
Introduction 41
Microorganisms almost universally reside in complex communities where individual 42 members interact with each other through physical and chemical networks. A major type of 43 chemical interaction is nutrient crossfeeding, in which microbes that lack the ability to synthesize 44 particular required nutrients (termed auxotrophs) obtain these nutrients from other organisms in 45 their community (Seth and Taga, 2014) . By understanding which organisms require nutrients and 46 which can produce them, we can predict specific metabolic interactions between members of a 47 microbial community (Abreu and Taga, 2016) . With the development of next-generation 48 sequencing, the genome sequences of tens of thousands of bacteria from diverse environments 49 are now available, leading to the possibility of predicting community interactions based on the 50 genomes of individual members. However, the power to predict the metabolism of an organism 51 by analyzing its genome remains limited. 52
The critical roles of cobamides (the vitamin B 12 family of enzyme cofactors) in the 53 metabolism of humans and diverse microbes has long been appreciated. Only recently, however, 54 has cobamide-dependent metabolism been recognized as a potential mediator of microbial 55 interactions (Degnan et al., 2014b; Seth and Taga, 2014) . Cobamides are used in a variety of 56 enzymes in prokaryotes, including those involved in central metabolic processes such as carbon 57 metabolism and the biosynthesis of methionine and deoxynucleotides (Fig. 1) . Some of the 58 functions carried out by cobamide-dependent pathways, such as acetogenesis via the Wood-59
Ljungdahl pathway in anaerobic environments, can be vital in shaping microbial communities 60 (Ragsdale and Pierce, 2008) . Cobamides are also used for processes that are important for human 61 use, such as reductive dehalogenation and natural product synthesis (Banerjee and Ragsdale, fewer than 45 out of 55 unique single copy genes ( Supplementary Fig. 1 ). To filter the remaining 110 genomes to one genome per species, we used name-based matching to create species categories, 111 in which each unique binomial name was considered a single species. The genome with the 112 highest unique single copy gene number and had an average single copy gene number closest to 113 1 was chosen to represent a species. If both scores were identical the representative genome was 114 chosen at random. For strains with genus assignments, but without species name assignments, we 115 considered each genome to be a species. The list of species was manually curated for species 116 duplicates caused by data entry errors ( Supplementary Table 2 ). 117 118
Detection of cobamide biosynthesis and dependence genes in genomes 119
Annotations from Enzyme Commission (EC) numbers 120 to improve specificity of the identified genes ( Supplementary Table 4 ). For example, EC: 126
For genes without functional annotations in the IMGer database, we chose sequences that 133 were genetically or biochemically characterized to use as the query genes in one-way BLASTP 134 (Altschul et al., 1997) against the filtered genomes using the IMGer "gene profile: genomes vs 135 genes" tool, accessed Jan-May 2017 ( Supplementary Table 4 ). 136
Output files for the cobamide genes were combined into a master file in Microsoft Excel 137 (Supplementary Table 1 , 2 sheet 2). This master file was used as input for custom python 2.7 138 code that interpreted the presence or absence of genes as predicted phenotypes. We used 139
Microsoft Excel and python for further analysis. Genomes were scored for the presence or 140 absence of cobamide-dependent enzymes and alternatives ( Supplementary Table 5 ) based on the 141 annotations in Supplementary Table 4 . We then created criteria for seven cobamide biosynthesis 142 phenotypes: very likely cobamide producer, likely cobamide producer, possible cobamide 143 producer, tetrapyrrole precursor salvager, cobinamide (Cbi) salvager, likely non-producer, and 144 very likely non-producer ( Supplementary Table 7 ) and classified genomes accordingly 145
( Supplementary Table 5 ). 146
To distinguish putative phenolic lower ligand attachment arsAB homologs from other 147 cobT homologs that are not known to produce phenolyl cobamides, IMGer entries for all genes 148 that were annotated as cobT homologs were downloaded. Tandem cobT homologs were defined 149 as those with sequential IMG gene IDs. This list of tandem cobT genes was then filtered by size 150 to eliminate genes encoding less than 300 or more than 800 amino acid residues, indicating 151 annotation errors (cobT is approximately 350 AA residues) (Supplementary Table 9 ). The 152 remaining tandem cobT homologs were assigned as putative arsAB homologs. 153
To identify the anaerobic benzimidazole biosynthesis genes bzaABCDEF, four new TIGR04385) were refined. Generally, the process for generating the new HMMs involved 156 performing a Position-Specific Iterated (PSI) BLAST search using previously classified 157 instances of the Bza proteins aligned in Jalview (Altschul et al., 1997; Waterhouse et al., 2009) . 158
Due to their similarity, BzaA, BzaB, and BzaF were examined together, as were BzaD and BzaE. 159
To help classify these sequences, Training Set Builder (TSB) was used (Haft and Haft, 2017) . 160
All six HMMs have not been assigned TIGRFAM accessions at the time of publication, but will 161 be included in the next TIGRFAM release, and are included as Supplementary Files. Details for 162 each protein are listed in the Supplementary Materials and Methods. 163
These protein sequences for 10591 of the filtered genomes were queried for each bza 164 HMM using hmm3search (HMMER3.1). Hits are only reported above the trusted cutoff defined 165 for each HMM ( Supplementary Table 8 ). A hit for bzaA and bzaB or bzaF indicated that the 166 genome had the potential to produce benzimidazole lower ligands. The specific lower ligand was 167 predicted based on the bza genes present . 168
We used BLASTP on IMGer to search for tetrapyrrole precursor biosynthesis genes that 169 appeared to be absent in the 201 species identified as tetrapyrrole precursor salvagers. Query 170 sequences used were the following: Rhodobacter sphaeroides HemA (GenPept C49845); 171
Clostridium saccharobutylicum DSM 13864 HemA, HemL, HemB, HemC, and HemD 172 (GenBank: AGX44136.1, AGX44131.1, AGX44132.1, AGX44134.1, AGX4133.4, 173 respectively). Since the C. saccharobutylicum HemD is a fusion protein with both the UroIII 174 synthase and UroIII methyltransferases domains, we additionally searched for the Bacillus after this analysis ( Supplementary Table 10 ). Genomes were classified as a particular type of 178 tetrapyrrole precursor salvager only if they were missing all genes upstream of a precursor. 179 180
Strains and growth conditions 181
Clostridium scindens ATCC 35704, Clostridium sporogenes ATCC 15579, and 182
Treponema primitia ZAS-2 (gift from Jared Leadbetter) were grown anaerobically with and 183 without added 5-aminolevulinic acid (1 mM for C. sporogenes and T. primitia, 0.5 mM for C. 184 scindens For all other bacteria excluding B. hydrogenotrophica, extracted corrinoids were 201 analyzed as above, except with a 1.5 ml/min flow rate and a 40°C column. Corrinoids were 202 eluted with the following method: 2% acidified methanol for 2 min, 2%-10% acidified methanol 203 in 0.1 min, and 10-40% acidified methanol over 9 min. 204
For B. hydrogenotrophica, corrinoids were analyzed as above with the following 205 changes. 10 µl samples were injected onto an Agilent Zorbax SB-Aq column (5 µm, 4.6 x 150) 206 with 1 ml/min flow rate at 30ºC. The samples were separated with a gradient of 25-34% acidified 207 methanol over 11 minutes, followed by 34-50% over 2 min and 50-75% over 9 minutes. 208
209
Results 210
Most bacteria are predicted to have at least one cobamide-dependent enzyme 211
We surveyed publicly available bacterial genomes for 51 functions involved in cobamide 212 biosynthesis, modification and salvage, as well as 15 cobamide-dependent enzyme families and 213 five cobamide-independent alternative enzymes and pathways. Because most of these genes have 214 been characterized and annotated, we used annotations from existing databases including 215 Enzyme Commission (EC) numbers, Pfam, TIGRFAM, Clusters of Orthologous Groups (COG), 216
and IMG Terms to identify most of these functions and used homology-based methods to 217 identify those for which annotations were unavailable. After filtering 44,802 publicly available 218 bacterial genomes to one genome per species and removing incomplete genomes, we had a 219 working data set of 11,436 species (for details, see Materials and Methods). 220
Our results indicate that the capability to use cobamides is widespread in bacteria. 86% of 221 species in the filtered data set have at least one of the 15 cobamide-dependent enzyme families 222 shown in Fig. 1 and Supplementary Table 4 , and 88% of these species have more than one family ( Fig. 3A ). This is consistent with previous analyses of smaller data sets ( Firmicutes and Actinobacteria (Fig. 3A) . The most abundant cobamide-dependent enzymes are 228 involved in core metabolic processes such as methionine synthesis and nucleotide metabolism, 229
whereas processes such as reductive dehalogenation and mercury methylation are less abundant 230 ( Fig. 3B , Supplementary Table 5 ). We also observe phylum-level differences in the relative 231 abundance of cobamide-dependent enzyme families ( Fig. 3B ), most notably the nearly complete 232 absence of epoxyqueuosine reductase in Actinobacteria. Nonetheless, the cobamide-dependent 233 methionine synthase (MetH) and, to a lesser extent, methylmalonyl-CoA mutase (MCM) and the 234 cobamide-dependent ribonucleotide reductase (RNR), are the most abundant cobamide-235 dependent enzyme families in all of the four phyla ( Fig. 3B ). 236
For some cobamide-dependent processes, cobamide-independent alternative enzymes or 237 pathways also exist ( Fig. 1 , right side of arrows). For example, we find that the occurrence of 238
MetH is more common than the cobamide-independent methionine synthase, MetE, but that most 239 bacteria have both enzymes ( Fig. 3C ). In contrast, cobamide-independent RNRs are found more 240 commonly than the cobamide-dependent versions, and 30% of genomes have both cobamide-241 dependent and -independent RNRs (Fig. 3C ). The cobamide-dependent propionate (which uses 242 MCM), ethanolamine, and glycerol/propanediol metabolisms appear more abundant than the 243 cobamide-independent alternatives ( Fig. 3C ). However, the abundance of the cobamide-244 dependent propionate function is overestimated because the MCM category includes mutases for 245 which cobamide-independent versions have not been found. The abundance of the latter two cobamide-independent functions may be underestimated, as they were identified based on 247 similarity to a limited number of sequences. We did not observe dramatic phylum-level 248 differences in the relative abundances of cobamide-dependent and -independent processes 249 (Supplementary Figure 2) . 250 251 37% of bacterial species are predicted to produce cobamides de novo 252
We analyzed the filtered data set to make informed predictions of cobamide biosynthesis 253 to determine the extent of cobamide biosynthesis in bacteria and to identify marker genes 254 overlap of some of the enzymes. We therefore relied on experimental data on cobamide 262 biosynthesis in diverse bacteria to inform our predictions, using 63 bacteria that are known to 263 produce cobamides (Table 1 , Supplementary Table 6 ), including 5 tested in this study (Table 1 , 264 bold names, Supplementary Figure 3 ). We identified a core set of eight functions shared by all or 265 all except one of the genomes of cobamide-producing bacteria (Table 1, gray highlight). These 266 core functions include three required for corrin ring biosynthesis: cbiL, cbiF and cbiC in the 267 anaerobic pathway, which are orthologous to cobI, cobM and cobH, respectively, in the aerobic pathway (Table 1, Fig. 2A ). An additional five nucleotide loop assembly functions were also 269 highly abundant in these genomes (Table 1) . 270
Our analysis additionally showed that the anaerobic and aerobic corrin ring biosynthesis 271 pathways cannot be distinguished based on their annotated gene content, presumably because 272 portions of the two pathways share orthologous genes (Table 1 ; Fig. 2A , dashed lines). Even the 273 cobalt chelatases, cobNST and cbiX/cbiK, are not exclusive to genomes with the aerobic or 274 anaerobic pathways, respectively (Table 1) . Cobalt chelatase annotations are also found in some 275 bacteria that lack most of the corrin ring and nucleotide loop assembly genes, suggesting that 276 there is overlap in annotations with other metal chelatases (Schubert et al., 1999) . 277
We next sought to predict cobamide biosynthesis capability across bacteria by analyzing 278 the filtered genome data set by defining different levels of confidence for predicting cobamide 279 biosynthesis (Supplementary Table 7 ). Annotations that are absent from the majority of genomes 280 of experimentally verified cobamide producers (cobR, pduX, and cobD) ( Table 1, Fig. 2A ), as 281 well as one whose role in cobamide biosynthesis has not been determined (cobW) (Haas et al., 282 2009) were excluded from these threshold-based definitions. We did not exclusively use the 283 small set of core functions identified in Table 1 because a correlation between the absence of 284 these genes and lack of cobamide biosynthesis ability has not been established. Using these 285 threshold-based definitions, we predict that 37% of bacteria in the data set have the potential to 286 produce cobamides ( Fig. 4 , black bars). 49% of species in the data set have at least one 287 cobamide-dependent enzyme but lack a complete cobamide biosynthetic pathway. Genomes in 288 the latter category can be further divided into non-producers, which contain fewer than five 289 corrin ring biosynthesis genes, and precursor salvagers, which contain distinct portions of the 290 pathway (described in a later section). The distribution of cobamide-dependent enzyme families also varies based on predicted cobamide biosynthesis, with predicted cobamide producers having 292 more cobamide-dependent enzyme families per genome than non-producers (Supplementary 293 Figure 4 ). 294
To assess whether the core functions could be used as markers, the threshold-based 295 assignments of cobamide biosynthesis were compared to the frequency of the three core corrin 296 ring functions. The presence of each core function alone is largely consistent with the threshold-297 based assignments, as each is present in 99% of genomes in the producer categories and in less 298 than 1% of the non-producers ( Table 2) . The presence of two or all three marker functions 299 matches the threshold-based predictions even more closely ( Table 2 ). The corrin ring markers 300 chosen in Table 1 are slightly more predictive of our threshold-based cobamide biosynthesis 301 classifications than cbiA/cobB (EC:6.3.5.11/EC:6.3.5.9), a previously selected marker used in 302 environmental DNA analysis (Bertrand et al., 2011); although cbiA/cobB was found in 99% of 303 predicted cobamide producers, is it also present in 2.6% of predicted non-producers and 46% of 304 precursor salvagers ( Supplementary Table 5 ). 305
As with the cobamide-dependent enzyme families, the four major phyla in the data set 306 have major differences in their predicted cobamide biosynthesis phenotypes ( Fig. 4 ). Around half 307 of Actinobacteria (57%) and Proteobacteria (45%) and 30% of Firmicutes are predicted to be 308 cobamide producers. In contrast, only 0.6% of Bacteroidetes are predicted to produce cobamides 309 de novo, yet 96% have at least one cobamide-dependent enzyme, suggesting that most members 310 of this phylum must acquire cobamides from other organisms in their environment. In addition, 311
Bacteroidetes have the highest relative proportion of species predicted to salvage Cbi via a 312 partial cobamide biosynthesis pathway, and most of the tetrapyrrole precursor salvagers are species are predicted to salvage precursors (Fig. 4) . These divisions reveal potential cobamide 315 and cobamide precursor crossfeeding requirements across phyla. Files). 96 genomes contain one or more bza genes, and 88 of these contain either bzaF or both 334 bzaA and bzaB, the first step necessary for the anaerobic biosynthesis of all four benzimidazoles 335 ( Fig. 5C , Supplementary Table 8 ). As seen with bluB, anaerobic benzimidazole biosynthesis 336 genes are highly enriched in cobamide producers (Fig. 5A ). Examining the set of bza genes in each genome allowed us to predict the structures of cobamides produced in 86 out of the 96 338 genomes ( Fig. 5C ). Based on the frequency of bluB and the bza genes, 24% of bacteria are 339 predicted to produce cobalamin, the cobamide required by humans. 340
To predict the biosynthesis of phenolyl cobamides, we searched for genomes containing 341 two adjacent cobT annotations, since the cobT homologs arsA and arsB, which together are 342 necessary for activation of phenolic compounds for incorporation into a cobamide, are encoded 343 in tandem (Chan and Escalante-Semerena, 2011). Using this definition, arsAB was found in only 344 27 species, and is almost entirely restricted to the class Negativicutes in the phylum Firmicutes, 345
which are the only bacteria reported to produce phenolyl cobamides (Stupperich and Eisinger, 346 1989; Men et al., 2014b) ( Fig. 5A, B , Supplementary Table 9 ). 347 42% of predicted cobamide producers in the data set do not have any of the 348 benzimidazole biosynthesis or phenolic attachment genes ( Fig. 5A ). However, bacteria that have 349 the α-ribazole kinase CblS (Fig. 5A, B , inner rings) and the transporter CblT (not included) are 350 predicted to use activated forms of lower ligand bases found in the environment ( Fig We observed an additional 201 genomes (1.7%) that lack one or more initial steps in 372 tetrapyrrole precursor biosynthesis but have complete corrin ring biosynthesis and nucleotide 373 loop assembly pathways, primarily in the Firmicutes ( Supplementary Table 7 ). After searching 374 these genomes manually for genes missing from the pathway, we designated 180 of these species 375 as tetrapyrrole precursor salvagers, a new classification of cobamide intermediate auxotrophs 376
( Fig. 6A, Supplementary Table 10 ). These organisms are predicted to produce cobamides only 377 when provided with a tetrapyrrole precursor or a later intermediate in the pathway. 378 379
Experimental validation of ALA dependence 380
The identification of putative tetrapyrrole precursor salvagers suggests either that these 381 bacteria are capable of taking up a tetrapyrrole precursor from the environment to produce a cobamide or that they synthesize the precursors through a novel pathway. We therefore tested 383 three putative tetrapyrrole precursor salvagers for their ability to produce corrinoids (cobamides 384 and other corrin ring-containing compounds) in the presence and absence of a tetrapyrrole 385 precursor. Clostridium scindens and Clostridium sporogenes, which are predicted to require 5-386 aminolevulinic acid (ALA), produced corrinoids in defined media only when ALA was supplied, 387 suggesting that they do not have a novel ALA biosynthesis pathway (Fig. 6B ). We tested an 388 additional predicted ALA salvager, the termite gut bacterium Treponema primitia ZAS-2, for 389 which a defined medium has not been developed. When cultured in medium containing yeast 390 autolysate, T. primitia produced trace amounts of corrinoids, and corrinoid production was 391 increased by supplementing this medium with ALA (Fig. 6B ). The ability of T. primitia to use 392 externally supplied ALA was further shown by its increased growth rate and cell density at 393 stationary phase when either cobalamin or ALA was added (Fig. 6C ). Together, these results 394 support the hypothesis that predicted ALA salvagers synthesize cobamides by taking up ALA 395 from the environment. The prevalence of cobamide-dependent enzymes in bacteria, coupled with the relative paucity of 409 de novo cobamide producers, underscores the ubiquity of both cobamide-dependent metabolism 410 and cobamide crossfeeding in microbial communities. Here, we additionally find that cobamide 411 production and use are unevenly distributed across the major phyla represented in the data set, 412 identify bacteria dependent on cobamide precursors, and predict cobamide structure. These 413 results underscore the widespread nutritional dependence of bacteria. 
analysis. 465
We predict that 32% of cobamide-dependent bacteria are unable to synthesize cobamides, 466 attach a preferred lower ligand to Cbi, or remodel corrinoids. This group of bacteria must take up 467 cobamides from their environment for use in their cobamide-dependent metabolisms. Given the 468 variable use of structurally different cobamides by different bacteria, the availability of specific 469 cobamides is likely critical to bacteria that are unable to synthesize cobamides or alter their 470 structure. The availability of preferred cobamides may limit the range of environments that these 471 organisms can inhabit. Variation in the abundance of different cobamides has been observed in 472 different environments. For example, in a TCE-contaminated groundwater enrichment culture, 5- precursors have been detected in biological samples, suggesting that they are available for uptake 495 in some environments. For example, UroIII was detected in human stool (Dobriner, 1937;  Although we confirmed experimentally the ALA dependence phenotype, we were unable to 498 detect ALA in several biological samples using a standard chemical assay or bioassay, 499 suggesting either that ALA is not freely available in these environments or is present at 500 concentrations lower than the 100 nM detection limit of these assays (data not shown). Based on 501 the ecosystem assignment information available for 48% of the genomes, 78% of tetrapyrrole 502 precursor salvagers are categorized as host-associated bacteria compared to 41% in the complete 503 filtered dataset. One interpretation of this finding is that tetrapyrrole precursors are provided by 504 the host, either from host cells that produce them as intermediates in heme biosynthesis 505 2009), may acquire a tetrapyrrole precursor from its insect host or other endosymbionts to be 510 able to provide methionine for itself and its host via the cobamide-dependent methionine 511 synthase. 17% of cobamide-requiring human gut bacteria lacked genes to make UroIII de novo 512 from glutamate, suggesting they could be UroIII salvagers (Degnan et al., 2014a) . 513
Nutritional dependence is nearly universal in bacteria. Auxotrophy for B vitamins, amino 514 acids, and nucleic acids is so common that these nutrients are standard components of bacterial 515 growth media. We speculate that the availability of cobamides in the environment, coupled with 516 the relative metabolic cost of cobamide biosynthesis, has driven selection for loss of the 517 cobamide biosynthesis pathway (Morris et al., 2012) . The large number of genomes with partial 518 cobamide biosynthesis pathways, namely in the "possible cobamide biosynthesis", "likely non-519 producer", and "Cbi salvager" classifications, suggests that some of these genomes are in the process of losing the cobamide biosynthesis pathway. At the same time, evidence for horizontal 521 acquisition of the cobamide biosynthesis pathway suggests an adaptive advantage for nutritional 522 independence for some bacteria (Morita et al., 2008; Lawrence and Roth, 1996) . Such 523 advantages could include early colonization of an environmental niche, ability to synthesize 524 cobamides with lower ligands that are not commonly available, or association with hosts that do 525 not produce cobamides. The analysis of the genomic potential of bacteria for cobamide use and 526 production presented here could provide a foundation for future studies of the evolution and 527 ecology of cobamide interdependence. 
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